Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Chimeric monoclonal antibody to shiga-toxin 1 and 2

EU orphan designation number: EU/3/05/301   
Active ingredient: Chimeric monoclonal antibody to shiga-toxin 1 and 2
Indication: Treatment of shiga-toxin producing bacterial infection.
Sponsor: Taro Pharmaceuticals Europe B.V.
Naritaweg 165, Telestone 8G, 1043BW Amsterdam, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2005 Orphan designation EMEA/OD/033/05 (2005)3335 of 26/08/2005
23/03/2012 Transfer of orphan designation EMEA/OD/033/05/T/01 (2012)2019 of 21/03/2012
11/06/2013 Transfer of orphan designation EMEA/OD/033/05/T/02 (2013)3672 of 7/06/2013
24/08/2016 Change of name and/or address of sponsor
25/02/2019 Transfer of orphan designation EMA/OD/0000003835 (2019)1636 of 21/02/2019